Skip to main content
Caplight Logo









AltrixBio Inc.

AltrixBio Inc.

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://www.altrixbio.com/

Last Round

Series A

Sep 16, 2025

Total Funding Raised

$6.5M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

AltrixBio Inc. is a biotechnology company that develops non-systemic oral therapies designed to replicate the metabolic benefits of bariatric surgery for the treatment of type 2 diabetes and obesity.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

non-systemic therapybariatric surgery in a pillobesity treatmenttype 2 diabetes treatmentGLP-1 alternativeoral obesity treatmentbariatric surgery alternativegut-restricted therapyluminal coatingweight loss druganti-obesity medicationAOMcardiometabolic therapyclinical-stage biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AltrixBio Inc. Comparables

Compare AltrixBio Inc. with similar companies based on industry and business-model similarity.

AltrixBio Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Syntis Bio, Inc.
93%
Glyscend Therapeutics
91%
Kallyope
79%

AltrixBio Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 16, 2025
SeedNov 6, 2020

Key People

Founding team and executive leadership

David Pass

President and Chief Executive Officer

Executive Team

AltrixBio Inc. Investors

Notable investors and investment history

AltrixBio Inc. investors
InvestorRounds
Arizona Tech InvestorsSeed
Taihill VentureSeed
MIT Alumni AngelsSeed
XFactor VenturesSeed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors increased 33% MoM.

  • May 16, 2026

    Monthly visitors increased 43% MoM.

AltrixBio Inc. Filings

Explore SEC and related filing metadata, where available.

AltrixBio Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about AltrixBio Inc.'s valuation, stock price, and market status.

Is AltrixBio Inc. a public or private company?

AltrixBio Inc. is a private company.

What is the current stock price of AltrixBio Inc.?

AltrixBio Inc. is a private company with no public stock price. Caplight tracks AltrixBio Inc.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is AltrixBio Inc. worth (valuation)?

Valuation information for AltrixBio Inc. is not publicly available.

Can I buy AltrixBio Inc. stock?

AltrixBio Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was AltrixBio Inc.'s last funding round?

AltrixBio Inc.'s most recent funding round was Series A on September 16, 2025.

Who are the main investors in AltrixBio Inc.?

Key investors in AltrixBio Inc. include Arizona Tech Investors, Taihill Venture, MIT Alumni Angels, XFactor Ventures.

Will AltrixBio Inc. IPO soon?

No public IPO plans have been announced for AltrixBio Inc..

How can I track AltrixBio Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AltrixBio Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range4
Year Founded2019
Last FundingSep 16, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?